← Back to all signals
RESEARCH PAPER ANALYSIS

Prospective insights into pediatric neurosurgery: transforming care through adverse event analysis.

AI interpretation is pending for this paper.

Open original publication →
PMID40540806
JournalJournal of neurosurgery. Pediatrics
Publication Date2025-06-20
Ingested2026-08-02 12:04 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

OBJECTIVE: Recent advancements in pediatric neurosurgery have significantly enhanced patient care and monitoring. Despite these improvements, the complexity of these procedures continues to pose a high risk of adverse events (AEs). The current literature lacks comprehensive AE data, underscoring a critical gap in research. This study addresses this void by using a prospectively collected database from a premier neurosurgical tertiary center, aiming to develop critical care guidelines, optimize resource allocation, and foster interdisciplinary collaborations to mitigate AEs. METHODS: This prospective study enrolled pediatric patients undergoing neurosurgery between January 2020 and December 2023. AEs were defined as any undesirable outcomes occurring within 30 days postoperatively, with each event peer-reviewed at discharge. RESULTS: Among the 1008 patients studied, ranging from newborns to 17-year-olds (mean age 10.5 years), 82.5% underwent elective procedures and 14.4% emergency procedures. The overall incidence of surgery-related AEs was 9.2%, with 5.2% requiring revision surgery. Cranial pathologies, accounting for 36.3% of interventions, were the most common, with wound infections and CSF leaks the most prevalent. The mortality rate was notably low at 0.4%, primarily attributable to severe underlying conditions such as medulloblastoma progression and severe traumatic brain injuries. Non-surgery-related AEs occurred at a rate of 2.4%. Logistic regression analysis identified age as a significant protective factor against postoperative complications, with each additional year reducing the odds of complications by approximately 5.4% (odds ratio 0.946, p = 0.002). Gender, however, was not a significant predictor of adverse outcomes. CONCLUSIONS: The study highlights a significantly low incidence of AEs in pediatric neurosurgery, demonstrating the effectiveness of systematic AE documentation and continuous data monitoring. Logistic regression analysis identified age as a significant protective factor against complications, while gender showed no significant association, underscoring the multifactorial nature of AE development. These findings provide actionable insights into patient risk stratification, particularly emphasizing the role of age, and contribute to enhancing patient education, guiding quality-based healthcare reforms, and supporting the implementation of prospective AE tracking systems to improve patient safety and care standards in pediatric neurosurgery.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Journey mapping paediatric oncology care in Saudi Arabia: A mixed-methods study. Health SA = SA Gesondheid 61.1 2 Not just exotropia: a case of persistent visual complaints in a 10-year-old boy. Strabismus 48.5 3 Brainstem glioblastoma in a neurofibromatosis type 1 patient: A rare but aggressive presentation. Journal of cancer research and therapeutics 56.4 4 Immature gastric teratoma. Journal of cancer research and therapeutics 54.0 5 Microsurgical Reconstruction of the Mandible: Patient Satisfaction and Aesthetic Outcomes. The Journal of craniofacial surgery 58.2 6 Maxillary Surgical Obturator Following Resection of an Odontogenic Myxoma in a Pediatric Patient. The Journal of craniofacial surgery 56.4 7 Prognostic Models for Optimal and Improved Health-Related Quality-of-Life Among Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. JCO clinical cancer informatics 58.0 8 Precision post-translational modification of PML defines neuroblastoma clinical behaviour. Clinical and translational medicine 65.7 9 Case Report: Early introduction of anti-GD2 immunotherapy during induction chemotherapy in high-risk neuroblastoma: two pediatric cases. Frontiers in oncology 62.82 10 GD2-targeted immunotherapy in pediatric bone sarcomas: a systematic review of emerging strategies and combination approaches. Frontiers in immunology 87.72 11 Gene-based immunotherapy in osteosarcoma: from oncolytic vectors to engineered immune cells. Frontiers in immunology 83.32 12 Minimal access surgery for the combined management of oesophageal duplication cyst and congenital pulmonary airway malformation in a 4-year-old boy. Journal of minimal access surgery 49.9 13 Bilateral Knee Osteonecrosis in an Adolescent With Leukemia on Prolonged Corticosteroids: Discordant Femoral-Tibial Findings on Bone Scan SPECT-CT. Clinical case reports 58.4 14 Transforming pediatric intensive care unit outcomes in pediatric hematology-oncology and hematopoietic stem cell transplantation through golden hour care in a low- and middle-income country: a 10-year analysis. Critical care science 67.4 15 Interim Positron Emission Tomography-Adapted Treatment Strategies for Classic Hodgkin Lymphoma: Insights From Korean Real-World Data. Journal of Korean medical science 84.54 16 Paediatric therapeutic development workshop on osteosarcoma. British journal of cancer 74.0 17 Nutritional outcomes associated with enteral versus parenteral nutritional support during intensive induction chemotherapy for acute myeloid leukemia. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 70.54 18 Circulating MicroRNAs as Diagnostic and Prognostic Biomarkers for Neuroblastoma: A Systematic Review and Exploratory Re-analysis. Molecular diagnosis & therapy 73.55 19 LACHT syndrome with branchial cyst in a female infant; case report and review of literature. BMC pediatrics 45.5 20 Enhancing Parents' Experiences of Paediatric Genomic Testing in Usual Outpatient Care: Insights From a Multi-Perspective Qualitative Study. Journal of paediatrics and child health 56.0 21 Cancer control after pausing treatment with larotrectinib in responding children with sarcoma and a TRK fusion: a plain language summary. Future oncology (London, England) 50.74 22 SRF fusion genes in myoid soft tissue tumors. The Journal of pathology 59.6 23 First-void urine and cervicovaginal brushes for vaginal microbiome profiling: a proof-of-concept study. Microbiology spectrum 62.9 24 Development and Psychometric Validation of the TF-Col: A Patient- and Caregiver-Reported Measure of Financial Toxicity in Oncology. Value in health regional issues 65.32 25 Clinical characteristics and outcomes of paediatric CNO: a retrospective cohort study with focus on zoledronic acid. Rheumatology (Oxford, England) 72.0 26 Long-Term Lung Function Monitoring after Childhood Cancer: From Risk Assessment to Prevention. Annals of the American Thoracic Society 28.5 27 Adverse Childhood Experiences and Oral Health in Adulthood. Caries research 62.5 28 Healthcare cost literacy in the united states: Cross-sectional estimates from a representative national sample. PloS one 60.6 29 Implementation of a National Pediatric Cancer Registry in Ethiopia: A systems ("A3") thinking approach. PloS one 56.4 30 A phase 1 feasibility trial of BE-CAR33, an "off-the-shelf" base-edited CAR33 T cell therapy for acute myeloid leukemia. Science translational medicine 86.52 31 Neighborhood factors and treatment outcomes in pediatric acute lymphoblastic leukemia: A REDIAL Consortium report. Cancer research communications 70.14 32 Presternal Subcutaneous Bronchogenic Cyst: An Unusual Ectopic Presentation Of A Congenital Lesion. Portuguese journal of cardiac thoracic and vascular surgery 37.4
PATIENT-FRIENDLY SUMMARY

Prospective insights into pediatric neurosurgery: transforming care through adverse event analysis.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic